Ken Griffin Volitionrx LTD Put Options Transaction History

Citadel Advisors LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	SELL	$1.39 - $2.02 $13,343 - $19,392	-9,600 Reduced 52.75%	8,600 $11,000
Q1 2023 May 15, 2023	BUY	$1.54 - $2.68 $10,010 - $17,420	6,500 Added 55.56%	18,200 $34,000
Q4 2022 Feb 14, 2023	BUY	$1.63 - $2.6 $19,071 - $30,420	11,700 New	11,700 $28,000

7.96M

39K

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $35M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.